✦ LIBER ✦

Low-dose tumour necrosis factor α and melphalan in hyperthermic isolated limb perfusion

✍ Scribed by Miss S. Hill; W. J. Fawcett; J. Sheldon; N. Soni; T. Williams; J. M. Thomas

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 337 KB
Volume: 80
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800800820

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multifocal soft tissue sarcoma: Limb sal

Multifocal soft tissue sarcoma: Limb salvage following hyperthermic isolated limb perfusion with high-dose tumor necrosis factor and melphalan

✍ Lev-Chelouche, Dina; Abu-Abeid, Subhi; Kollander, Yehuda; Meller, Isaac; Isakov, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 2 views

## Background and Objectives: The prognosis for recurrent multifocal limb soft tissue sarcoma (STS) is dismal due to systemic spread. However, many of these patients undergo amputation due to ineffective local control. The purpose of the present study was to determine whether isolated limb perfusi

Complete remission of advanced cutaneous

Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-α and melphalan

✍ A.C. Häffner; K. Zepter; T. Fritz; R. Dummer; F.J. Lejeune; G. Burg 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Hyperthermic Isolated Limb Perfusion Wit

Hyperthermic Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan in Advanced Soft-Tissue Sarcomas: Histopathological Considerations

✍ Josephine Issakov; Ofer Merimsky; Mordechai Gutman; Yehuda Kollender; Dina Lev-C 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 657 KB

Synergistic antitumour effect of recombi

Synergistic antitumour effect of recombinant human tumour necrosis factor a with melphalan in isolated limb perfusion in the rat

✍ Dr E. R. Manusama; P. T. G. A. Nooijen; J. Stavast; N. M. C. Durante; R. L. Marq 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 510 KB

High dose tumor necrosis factor-α and me

High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

✍ Mordechai Gutman; Moshe Inbar; Dina Lev-Shlush; Subhi Abu-Abid; Martha Mozes; Sa 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

## BACKGROUND. Recombinant tumor necrosis factor-a (rTNF-a) is

Absence of Severe Systemic Toxicity Afte

Absence of Severe Systemic Toxicity After Leakage-Controlled Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan

✍ Bart C. Vrouenraets; Bin B. R. Kroon; Aernout C. Ogilvie; Albert N. van Geel; Om 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 94 KB